Abstract
This recent research work was aimed to develop the oral dissolving films of gliclazide. Solid dispersions of gliclazide using natural polymers such as hupu gum (HG), guar gum (GG) and xanthan gum (XG) were prepared by kneading technique and the optimized solid dispersion was exploited to develop the gliclazide films. Different grades of HPMC (E5, 50 cps and K4M) were used to develop the films by adapting solvent casting method. Six formulations (FG1-FG6) of gliclazide films were prepared. The films were evaluated for their thickness, tensile strength, elongation, weight variation, folding endurance, drug content uniformity and surface pH and obtained satisfactory results. The films were assessed for their compatibility between the drug and excipients by FTIR and DSC techniques. The film formulations were subjected to disintegration, in vitro drug release and pharmacodynamic studies. From the results FG4 formulation was found as best formulation which contains HPMC K4M and gliclazide solid dispersion with guar gum at weight ratio of 1:2. The formulation had showed excellent film characteristics such as disintegration time of 64 sec and drug release was 97.30 % within 10 min. The optimized film formulation (FG4) showed excellent stability over 45 days when stored at 40°C /60% RH. The pharmacodynamic study in animal models (rats) proved that fast dissolving films of gliclazide produced a faster onset of action compared to that of conventional formulation.
Keywords: Blood glucose levels, elongation, folding endurance, solvent casting, tensile strength, wistar rats.
Drug Delivery Letters
Title:Formulation and Characterization of Gliclazide Oral Dissolving Films
Volume: 4 Issue: 3
Author(s): Rajesh Kaza, Prasanna R. Yalavarthi and Ravouru Nagaraju
Affiliation:
Keywords: Blood glucose levels, elongation, folding endurance, solvent casting, tensile strength, wistar rats.
Abstract: This recent research work was aimed to develop the oral dissolving films of gliclazide. Solid dispersions of gliclazide using natural polymers such as hupu gum (HG), guar gum (GG) and xanthan gum (XG) were prepared by kneading technique and the optimized solid dispersion was exploited to develop the gliclazide films. Different grades of HPMC (E5, 50 cps and K4M) were used to develop the films by adapting solvent casting method. Six formulations (FG1-FG6) of gliclazide films were prepared. The films were evaluated for their thickness, tensile strength, elongation, weight variation, folding endurance, drug content uniformity and surface pH and obtained satisfactory results. The films were assessed for their compatibility between the drug and excipients by FTIR and DSC techniques. The film formulations were subjected to disintegration, in vitro drug release and pharmacodynamic studies. From the results FG4 formulation was found as best formulation which contains HPMC K4M and gliclazide solid dispersion with guar gum at weight ratio of 1:2. The formulation had showed excellent film characteristics such as disintegration time of 64 sec and drug release was 97.30 % within 10 min. The optimized film formulation (FG4) showed excellent stability over 45 days when stored at 40°C /60% RH. The pharmacodynamic study in animal models (rats) proved that fast dissolving films of gliclazide produced a faster onset of action compared to that of conventional formulation.
Export Options
About this article
Cite this article as:
Kaza Rajesh, R. Yalavarthi Prasanna and Nagaraju Ravouru, Formulation and Characterization of Gliclazide Oral Dissolving Films, Drug Delivery Letters 2014; 4 (3) . https://dx.doi.org/10.2174/22103031113036660013
DOI https://dx.doi.org/10.2174/22103031113036660013 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Metabolic Enzyme System and Transport Pathways in Chronic Kidney Diseases
Current Drug Metabolism The Biological and Clinical Activity of Anti-Malarial Drugs In Autoimmune Disorders
Current Rheumatology Reviews Genetic and Environmental Risk Factors in Hyperuricaemia and Common Gout
Current Rheumatology Reviews Cardiovascular Involvement in Pediatric Systemic Autoimmune Diseases: The Emerging Role of Noninvasive Cardiovascular Imaging
Inflammation & Allergy - Drug Targets (Discontinued) The Dynamics of the Hypothalamic-Pituitary-Ovarian Axis, ReproductivePerformance and Sexuality Following Bariatric Surgery
Current Women`s Health Reviews Non Peptidic Urotensin II Antagonists: Perspectives for a New Class of Drugs
Cardiovascular & Hematological Agents in Medicinal Chemistry Beneficial Effects of Herbs, Spices and Medicinal Plants on the Metabolic Syndrome, Brain and Cognitive Function
Central Nervous System Agents in Medicinal Chemistry Improving the Efficiency and Safety of Aspirin by Complexation with the Natural Polysaccharide Arabinogalactan
Current Drug Delivery Effects of Hypertension, Diabetes Mellitus, Obesity and Other Factors on Kidney Haemodynamics
Current Vascular Pharmacology Esophagogastric Cancer: Integration of Targeted Therapies into Systemic Chemotherapy
Current Cancer Drug Targets Obesity, Diabetes and Cardiovascular Diseases in India: Public Health Challenges
Current Diabetes Reviews Targeting Kinin Receptors for the Treatment of Neurological Diseases
Current Pharmaceutical Design Gestational Diabetes and the Metabolic Syndrome: Can Obesity and Small, Dense Low Density Lipoproteins be Key Mediators of this Association?
Current Pharmaceutical Biotechnology Critical Questions for Preclinical Trials on Safety and Efficacy of Vascular Endothelial Growth Factor-Based Therapeutic Angiogenesis for Ischemic Stroke
CNS & Neurological Disorders - Drug Targets EPC Dysfunction and Immune Networks: Translating Opportunities for Clinical Setting in Personalized Medicine
Current Medicinal Chemistry Ligustrazine Derivatives. Part 6: Design, Synthesis and Evaluation of Novel Ligustrazinyl Acylguanidine Derivatives as Potential Cardiovascular Agents
Medicinal Chemistry Telemedicine, Genomics and Personalized Medicine: Synergies and Challenges
Current Pharmacogenomics and Personalized Medicine Advanced Nebulizer Designs Employing Vibrating Mesh/Aperture Plate Technologies for Aerosol Generation
Current Drug Delivery Vascular Risk Factors and Alzheimer’s Disease Pathogenesis: Are Conventional Pharmacological Approaches Protective For Cognitive Decline Progression?
CNS & Neurological Disorders - Drug Targets Diagnosis and Management of Hypertensive Emergencies Complicating Pregnancy
Current Women`s Health Reviews